Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Healthy Volunteers
Status:
Completed
Trial end date:
2002-12-20
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to show that the product of the
new production process has a similar pharmacological profile to the traditional process used
for the current commercial product Actrapid®.